Compass Chiropractic and Massage

Benadryl use shown to increase dementia risk

Est. Reading: 3 minutes

Benadryl use shown to increase dementia risk

The Connection Between Benadryl and Dementia: What You Need to Know

Benadryl, a common over-the-counter medication used to treat allergies, insomnia, and colds, has come under increasing scrutiny due to its potential link to cognitive decline and dementia. The active ingredient in Benadryl, diphenhydramine, is classified as a first-generation antihistamine with strong anticholinergic properties—a characteristic now closely associated with an increased risk of developing dementia, especially with long-term or high-dose use.

What Are Anticholinergics?

Anticholinergics are drugs that block the action of acetylcholine, a neurotransmitter involved in many functions, including memory, attention, muscle control, and digestion. While blocking acetylcholine can help relieve certain symptoms—like sneezing, runny nose, or motion sickness—it can also interfere with brain function.

Diphenhydramine, along with other medications like tricyclic antidepressants, bladder relaxants, and some sleep aids, is known for its strong anticholinergic effects.

The Research Behind the Link

Several large, well-designed studies have found a connection between long-term use of anticholinergic medications and an increased risk of dementia:

  • A 2015 study published in JAMA Internal Medicine followed over 3,400 older adults for more than 7 years. It found that people who used high amounts of anticholinergic medications—including diphenhydramine—had a 54% increased risk of developing dementia compared to non-users.
  • The University of Washington/Group Health study tracked medication use in people aged 65 and older. It concluded that cumulative anticholinergic use (even at standard doses) significantly raised the risk of dementia—even if use had stopped years before diagnosis.
  • A 2021 review in The Lancet Neurology emphasized the importance of reducing exposure to anticholinergic drugs as part of dementia prevention strategies.

Importantly, the dementia risk appears to be dose- and duration-dependent. Occasional or short-term use of Benadryl is unlikely to have a major impact, but regular use over long periods can be problematic.

Who Is Most at Risk?

  • Older adults: The aging brain is more vulnerable to anticholinergic effects.
  • People with existing cognitive decline or mild cognitive impairment (MCI): These individuals may experience accelerated progression with anticholinergic exposure.
  • Chronic users: Those who use Benadryl nightly for sleep, or who take it regularly for allergies or anxiety, are at greater risk.

Common Anticholinergic Symptoms to Watch For

Even before dementia develops, anticholinergic medications like Benadryl can cause short-term cognitive symptoms such as:

  • Brain fog
  • Memory lapses
  • Difficulty concentrating
  • Confusion, especially in the elderly

These symptoms may be reversible upon stopping the medication, but in cases of long-term use, some changes may become permanent.

Safer Alternatives

If you’re using Benadryl regularly for allergies, sleep, or other issues, consider these alternatives:

  • For allergies: Check out our Allergies without medication part 1 and part 2.
  • For sleep: Cognitive behavioral therapy for insomnia (CBT-I), melatonin, magnesium, and improved sleep hygiene are safer long-term options.
  • For colds: Saline nasal sprays, Xclear, steam, and rest may be safer for congestion relief without affecting cognition.

The Bottom Line

Benadryl and other strong anticholinergic medications may increase the risk of dementia when used frequently or long-term—especially in older adults. While occasional use is unlikely to pose serious harm, it’s important to be aware of the cumulative impact these medications can have on brain health.

If you or a loved one are using Benadryl regularly, consult a healthcare provider about safer alternatives. Protecting your cognitive health may start with reevaluating your medicine cabinet.


References:

  1. Gray, S. L., et al. (2015). "Cumulative Use of Strong Anticholinergics and Incident Dementia." JAMA Internal Medicine, 175(3), 401–407.
  2. Coupland, C. A., et al. (2019). "Anticholinergic drug exposure and the risk of dementia: a nested case-control study." JAMA Internal Medicine, 179(8), 1084–1093.
  3. Risacher, S. L., et al. (2016). "Association of Anticholinergic Medication Use With Brain Metabolism and Cognitive Decline." JAMA Neurology, 73(6), 721–732.
Back To Blog
Copyright © 2026 All Rights Reserved
Call Now
Send A Text
chevron-up-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram